Although it is reported that certain benign diseases such as lymphadenitis and malignant diseases such as lung adenocarcinoma may also exhibit PSMA uptake (10), its remarkable sensitivity and specificity for PCa continue to establish it as a dedicated imaging modality for patients with PCa. This evidence concerns the gene FOLH1 and posterior cortical atrophy.